Glass Delamination in Pharmaceutical Containers (USP 1660)

Delamination is characterized by the formation of glass flakes (lamellae), which are shed from the internal surface of the glass container. These lamellae cause contamination and have the potential to release harmful compounds that could negatively impact the drug products and consumers. It is important to remain FDA compliant using USP 1660 guided testing that verifies no inner surface glass delamination of the container system. Our team at Intertek developed a custom comprehensive testing program to meet the needs of USP 1660.

Please complete the form below to download our fact sheet and learn more.